These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12659773)

  • 1. New carrier for specific delivery of drugs to the brain.
    Sheha M; Al-Tayeb A; El-Sherief H; Farag H
    Bioorg Med Chem; 2003 Apr; 11(8):1865-72. PubMed ID: 12659773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain.
    Hassan HA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
    Bioorg Med Chem; 2009 Feb; 17(4):1681-92. PubMed ID: 19147368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1, 2-dihydroisoquinoline-N-acetic acid derivatives as new carriers for brain-specific delivery II: delivery of phenethylamine as model drug.
    Mahmoud S; Sheha M; Aboul-Fadl T; Farag H
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):258-63. PubMed ID: 12916061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brain.
    El-Sherbeny MA; Al-Salem HS; Sultan MA; Radwan MA; Farag HA; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Oct; 336(10):445-55. PubMed ID: 14582121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-malonyl-1,2-dihydroisoquinoline as a novel carrier for specific delivery of drugs to the brain.
    Abdel-Aziz M; Abuo-Rahma Gel-D; Hassan HA; Farag HH
    Arch Pharm (Weinheim); 2010 Jan; 343(1):54-60. PubMed ID: 19899103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
    Foucout L; Gourand F; Dhilly M; Bohn P; Dupas G; Costentin J; Abbas A; Marsais F; Barré L; Levacher V
    Org Biomol Chem; 2009 Sep; 7(18):3666-73. PubMed ID: 19707670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials.
    Murakami T; Shek E; Pop E; Bodor N
    J Pharm Sci; 1989 Sep; 78(9):732-7. PubMed ID: 2585265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and CSF specific chemical delivery systems for beta-lactam antibiotics. Study of two dihydropyridine derivatives of benzylpenicillin in rabbits and dogs.
    Wu WM; Pop E; Shek E; Clemmons R; Bodor N
    Drug Des Deliv; 1990 Dec; 7(1):33-43. PubMed ID: 2096832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dihydropyridine carrier system for sustained delivery of 2',3'-dideoxynucleosides to the brain.
    Palomino E; Kessel D; Horwitz JP
    J Med Chem; 1989 Mar; 32(3):622-5. PubMed ID: 2918510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved delivery through biological membranes XXV. Enhanced and sustained delivery of trifluorothymidine to the brain using a dihydropyridine in equilibrium pyridinium salt type redox delivery system.
    el-Koussi A; Bodor N
    Drug Des Deliv; 1987 May; 1(4):275-83. PubMed ID: 3151241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-specific delivery of naproxen using different carrier systems.
    Mahmoud S; Mohammad A
    Arch Pharm (Weinheim); 2010 Nov; 343(11-12):639-47. PubMed ID: 21110306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved delivery through biological membranes. XXXVII. Synthesis and stability of novel redox derivatives of naproxen and indomethacin.
    Phelan MJ; Bodor N
    Pharm Res; 1989 Aug; 6(8):667-76. PubMed ID: 2813259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
    Wu WM; Pop E; Shek E; Bodor N
    J Med Chem; 1989 Aug; 32(8):1782-8. PubMed ID: 2754705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluations of dihydroquinoline- and dihydroisoquinoline-based targetor moieties for brain-specific chemical delivery systems.
    Bodor N; Farag HH; Barros MD; Wu WM; Buchwald P
    J Drug Target; 2002 Feb; 10(1):63-71. PubMed ID: 11996088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative activation of dihydropyridine amides to reactive acyl donors.
    Funder ED; Trads JB; Gothelf KV
    Org Biomol Chem; 2015 Jan; 13(1):185-98. PubMed ID: 25358438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents.
    Woodard PA; Winwood D; Brewster ME; Estes KS; Bodor N
    Drug Des Deliv; 1990 May; 6(1):15-28. PubMed ID: 2078285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved delivery through biological membranes. 13. Brain-specific delivery of dopamine with a dihydropyridine in equilibrium with pyridinium salt type redox delivery system.
    Bodor N; Farag HH
    J Med Chem; 1983 Apr; 26(4):528-34. PubMed ID: 6834384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
    Sheha M
    Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
    Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved delivery through biological membranes. 11. A redox chemical drug-delivery system and its use for brain-specific delivery of phenylethylamine.
    Bodor N; Farag HH
    J Med Chem; 1983 Mar; 26(3):313-8. PubMed ID: 6827552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.